209 related articles for article (PubMed ID: 31734419)
1. Effect of Sevoflurane Postconditioning on the Incidence of Symptomatic Cerebral Hyperperfusion After Revascularization Surgery in Adult Patients with Moyamoya Disease.
Yoon HK; Oh H; Lee HC; Cho WS; Kim JE; Park JW; Choi H; Park HP
World Neurosurg; 2020 Feb; 134():e991-e1000. PubMed ID: 31734419
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.
Hwang JW; Yang HM; Lee H; Lee HK; Jeon YT; Kim JE; Lim YJ; Park HP
Br J Anaesth; 2013 May; 110(5):773-9. PubMed ID: 23274781
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
[TBL] [Abstract][Full Text] [Related]
5. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
[TBL] [Abstract][Full Text] [Related]
6. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
[TBL] [Abstract][Full Text] [Related]
7. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
[TBL] [Abstract][Full Text] [Related]
8. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
[TBL] [Abstract][Full Text] [Related]
9. Preoperative platelet count may predict postoperative symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in moyamoya patients.
Jo WY; Oh H; Kim H; Yoon HK; Lee HC; Cho WS; Kim JE; Park HP
Clin Neurol Neurosurg; 2020 Dec; 199():106260. PubMed ID: 33031987
[TBL] [Abstract][Full Text] [Related]
10. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study.
Seo H; Ryu HG; Son JD; Kim JS; Ha EJ; Kim JE; Park HP
Medicine (Baltimore); 2016 Dec; 95(52):e5712. PubMed ID: 28033272
[TBL] [Abstract][Full Text] [Related]
12. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
Narisawa A; Fujimura M; Shimizu H; Tominaga T
No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
[TBL] [Abstract][Full Text] [Related]
13. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
[TBL] [Abstract][Full Text] [Related]
14. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease.
Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T
Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
Fujimura M; Kaneta T; Shimizu H; Tominaga T
Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
[TBL] [Abstract][Full Text] [Related]
16. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
[TBL] [Abstract][Full Text] [Related]
17. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
[TBL] [Abstract][Full Text] [Related]
18. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative infrared brain surface blood flow monitoring during superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: clinical implication of the gradation value in postoperative clinical course--a case report.
Nakagawa A; Fujimura M; Arafune T; Suzuki H; Sakuma I; Tominaga T
Acta Neurochir Suppl; 2008; 102():159-63. PubMed ID: 19388309
[TBL] [Abstract][Full Text] [Related]
20. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease.
Kaku Y; Iihara K; Nakajima N; Kataoka H; Fukuda K; Masuoka J; Fukushima K; Iida H; Hashimoto N
J Cereb Blood Flow Metab; 2012 Nov; 32(11):2066-75. PubMed ID: 22850406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
